We are live on ! Find out more
PG

Proffitt & Goodson Portfolio holdings

AUM $728M Turnover 11.9%
1-Year Est. Return 18.62%
This Fund
S&P 500
This Quarter Est. Return
+0.36%
1 Year Est. Return
+18.62%
3 Year Est. Return
+48.49%
5 Year Est. Return
+42.28%
10 Year Est. Return
+158.21%
AUM
$175M
AUM Growth
+$5.04M
Cap. Flow
+$4.04M
Cap. Flow %
2.31%
Top 10 Hldgs %
78.82%
Holding
45
New
4
Increased
30
Reduced
9
Closed
2
Avg Time Held
2.1 years
Top 10 Avg Time Held
2.2 years
Top 20 Avg Time Held
1.8 years

Top Buys

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$1.21M
2
BAC icon
Bank of America
BAC
+$1.13M
3
LDOS icon
Leidos
LDOS
+$1M
4
AAPL icon
Apple
AAPL
+$509K
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$394K

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.19M
2
COP icon
ConocoPhillips
COP
+$972K
3
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$487K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$66K
5
T icon
AT&T
T
+$18K

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.91%
2 Technology 5.03%
3 Healthcare 3%
4 Industrials 2.93%
5 Consumer Staples 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
WFM
26
DELISTED
Whole Foods Market Inc
WFM
$1.23M 0.7%
39,475
+1,615
+4% +$50.5K
2015 Q4
1 quarter
MSFT icon
27
Microsoft
MSFT
$4.01T
$1.2M 0.69%
21,721
-100
-0.5% -$5.24K
2013 Q2
11 quarters
INTC icon
28
Intel
INTC
$504B
$1.19M 0.68%
36,720
+526
+1% +$16.1K
2013 Q2
11 quarters
KRE icon
29
State Street SPDR S&P Regional Banking ETF
KRE
$3.31B
$1.19M 0.68%
31,564
+4,824
+18% +$177K
2014 Q1
8 quarters
IBB icon
30
iShares Biotechnology ETF
IBB
$10.6B
$1.18M 0.67%
+13,560
New +$1.21M
2016 Q1
0 quarters
EMR icon
31
Emerson Electric
EMR
$90.4B
$1.12M 0.64%
20,639
+235
+1% +$11.3K
2013 Q2
11 quarters
ZBH icon
32
Zimmer Biomet
ZBH
$18B
$1.1M 0.63%
10,619
-62
-0.6% -$6K
2013 Q2
11 quarters
PG icon
33
Procter & Gamble
PG
$365B
$1.09M 0.62%
13,194
-159
-1% -$12.8K
2013 Q2
11 quarters
SLB icon
34
SLB Ltd
SLB
$71.8B
$1.07M 0.61%
14,524
+1,736
+14% +$122K
2013 Q2
11 quarters
LDOS icon
35
Leidos
LDOS
$15.6B
$1.06M 0.61%
+21,019
New +$1M
2016 Q1
0 quarters
PH icon
36
Parker-Hannifin
PH
$121B
$1.03M 0.59%
9,257
-50
-0.5% -$5.02K
2013 Q2
11 quarters
AA icon
37
Alcoa
AA
$10.7B
$1M 0.57%
43,473
+783
+2% +$15.9K
2015 Q3
2 quarters
MNDT
38
DELISTED
Mandiant, Inc. Common Stock
MNDT
$910K 0.52%
50,610
+2,530
+5% +$41.2K
2015 Q4
1 quarter
DD icon
39
DELISTED
Du Pont De Nemours E I
DD
$859K 0.49%
13,564
+195
+1% +$11.7K
2013 Q2
11 quarters
TWTR
40
DELISTED
Twitter, Inc.
TWTR
$645K 0.37%
38,950
+2,080
+6% +$36.4K
2015 Q3
2 quarters
JPM icon
41
JPMorgan Chase
JPM
$891B
$288K 0.16%
4,860
+230
+5% +$13.4K
2015 Q3
2 quarters
TSLA icon
42
Tesla
TSLA
$1.43T
$278K 0.16%
+18,150
New +$239K
2016 Q1
0 quarters
EEM icon
43
iShares MSCI Emerging Markets ETF
EEM
$29.6B
$271K 0.16%
+7,925
New +$246K
2016 Q1
0 quarters
COP icon
44
ConocoPhillips
COP
$170B
– –
-20,808
Closed -$972K –
XBI icon
45
State Street SPDR S&P Biotech ETF
XBI
$9.9B
– –
-17,015
Closed -$1.19M –
1
2

Similar funds

VU
Vanderbilt University Nashville, Tennessee $728M AUM 24.41% 1-Year Est. Return
ITC
Inspire Trust Company Reno, Nevada $727M AUM 20.31% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
CCP
Clifford Capital Partners Alpine, Utah $727M AUM 28.47% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $730M AUM 53.51% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $731M AUM 34.87% 1-Year Est. Return
MCM
Morton Capital Management Calabasas, California $731M AUM 20.62% 1-Year Est. Return

Proffitt & Goodson's Q1 2016 Portfolio in Review

As of Q1 2016, Proffitt & Goodson held 45 positions worth $175M, up 3% from $170M the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Proffitt & Goodson's Q1 2016 filing shows 4 new, 30 increased, 9 reduced and 2 closed positions. Its largest new stake was iShares Biotechnology ETF: 13,560 shares worth $1.18M. The largest sale was State Street SPDR S&P Biotech ETF, an estimated $1.19M.

By sector, the portfolio is most concentrated in Miscellaneous at 80% of assets, down from 82% a quarter earlier, followed by Technology and Healthcare.

  • Proffitt & Goodson's largest Q1 2016 buy was iShares Biotechnology ETF: 13,560 shares worth $1.18M.
  • Proffitt & Goodson added most to Bank of America in Q1 2016, an estimated $1.13M increase.
  • Proffitt & Goodson's biggest Q1 2016 reduction was State Street Financial Select Sector SPDR ETF, cutting an estimated $487K.
  • Proffitt & Goodson fully exited State Street SPDR S&P Biotech ETF in Q1 2016, selling an estimated $1.19M.
  • Proffitt & Goodson's ten largest holdings make up 79% of its $175M portfolio in Q1 2016.
  • Proffitt & Goodson opened 4 new positions and closed 2 in Q1 2016.
  • Proffitt & Goodson's portfolio value rose 3% quarter-over-quarter to $175M.

Based on Proffitt & Goodson's 13F filing for Q1 2016, filed 19 Apr 2016.